Abstract

We introduce a machine learning-based analysis to predict the immunohistochemical (IHC) labeling index for the cell proliferation marker Ki67/MIB1 on cancer tissues based on morphometrical features extracted from hematoxylin and eosin (H&E)-stained formalin-fixed, paraffin-embedded (FFPE) tumor tissue samples. We provided a proof-of-concept prediction of the Ki67/MIB1 IHC positivity of cancer cells through the definition and quantitation of single nuclear features. In the first instance, we set our digital framework on Ki67/MIB1-stained OSCC (oral squamous cell carcinoma) tissue sample whole slide images, using QuPath as a working platform and its integrated algorithms, and we built a classifier in order to distinguish tumor and stroma classes and, within them, Ki67-positive and Ki67-negative cells; then, we sorted the morphometric features of tumor cells related to their Ki67 IHC status. Among the evaluated features, nuclear hematoxylin mean optical density (NHMOD) presented as the best one to distinguish Ki67/MIB1 positive from negative cells. We confirmed our findings in a single-cell level analysis of H&E staining on Ki67-immunostained/H&E-decolored tissue samples. Finally, we tested our digital framework on a case series of oral squamous cell carcinomas (OSCC), arranged in tissue microarrays; we selected two consecutive sections of each OSCC FFPE TMA (tissue microarray) block, respectively stained with H&E and immuno-stained for Ki67/MIB1. We automatically detected tumor cells in H&E slides and generated a “false color map” (FCM) based on NHMOD through the QuPath measurements map tool. FCM nearly coincided with the actual immunohistochemical result, allowing the prediction of Ki67/MIB1 positive cells in a direct visual fashion. Our proposed approach provides the pathologist with a fast method of identifying the proliferating compartment of the tumor through a quantitative assessment of the nuclear features on H&E slides, readily appreciable by visual inspection. Although this technique needs to be fine-tuned and tested on larger series of tumors, the digital analysis approach appears to be a promising tool to quickly forecast the tumor’s proliferation fraction directly on routinely H&E-stained digital sections.

Highlights

  • The assessment of the replicative activity of the cells and their ability to proliferate, or the frequency they enter into the mitotic phase of the cell cycle, are major determinants of the biologic behavior of several human tumors

  • We explored the possibility of predicting Ki67 labeling using hematoxylin and eosin (H&E)-stained digitalized histological sections, by uncovering morphological and densitometric features that could distinguish between proliferative and quiescent neoplastic cells, such as nucleus area and perimeter, that reflect the increase in dimension of the nuclei, and hematoxylin optical density, that reflects chromatin condensation

  • The vast majority of routine practice in surgical pathology relies on histopathological examination of small biopsies

Read more

Summary

Introduction

The assessment of the replicative activity of the cells and their ability to proliferate, or the frequency they enter into the mitotic phase of the cell cycle, are major determinants of the biologic behavior of several human tumors. The protein Ki67 has been suggested as a diagnostic biomarker in several tumors, being overexpressed in malignant tumor tissues compared to normal ones [7,8], and it correlates to tissue differentiation in an inversely proportional fashion; many studies have shown a correlation between the Ki67/MIB-1 labeling index and human cancer grading [4,9,10,11,12,13,14]. It correlates with the clinical tumors’ stage and occult metastasis [15,16,17,18], and Ki67 expression evaluation, in combination with other histopathological characteristics, may represent an indicator of the risk of tumor recurrence [19]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call